Carvedilol targets human K2P3.1 (TASK1) K+ leak channels

BACKGROUND AND PURPOSE Human K2P3.1 (TASK1) channels represent potential targets for pharmacological management of atrial fibrillation. K2P channels control excitability by stabilizing membrane potential and by expediting repolarization. In the heart, inhibition of K2P currents by class III antiarrh...

Full description

Saved in:
Bibliographic Details
Main Authors: Staudacher, Kathrin (Author) , Staudacher, Ingo (Author) , Ficker, Eckhard (Author) , Seyler, Claudia (Author) , Gierten, Jakob (Author) , Kisselbach, Jana (Author) , Rahm, Ann-Kathrin (Author) , Trappe, Kerstin (Author) , Schweizer, Patrick Alexander (Author) , Becker, Rüdiger (Author) , Katus, Hugo (Author) , Thomas, Dierk (Author)
Format: Article (Journal)
Language:English
Published: 15 March 2011
In: British journal of pharmacology
Year: 2011, Volume: 163, Issue: 5, Pages: 1099-1110
ISSN:1476-5381
DOI:10.1111/j.1476-5381.2011.01319.x
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1111/j.1476-5381.2011.01319.x
Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1476-5381.2011.01319.x
Get full text
Author Notes:K. Staudacher, I. Staudacher, E. Ficker, C. Seyler, J. Gierten, J. Kisselbach, A.-K. Rahm, K. Trappe, P.A. Schweizer, R. Becker, H.A. Katus and D. Thomas

MARC

LEADER 00000caa a2200000 c 4500
001 1819520641
003 DE-627
005 20240418111725.0
007 cr uuu---uuuuu
008 221020s2011 xx |||||o 00| ||eng c
024 7 |a 10.1111/j.1476-5381.2011.01319.x  |2 doi 
035 |a (DE-627)1819520641 
035 |a (DE-599)KXP1819520641 
035 |a (OCoLC)1389765550 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Staudacher, Kathrin  |d 1985-  |e VerfasserIn  |0 (DE-588)1031541551  |0 (DE-627)736631321  |0 (DE-576)379021889  |4 aut 
245 1 0 |a Carvedilol targets human K2P3.1 (TASK1) K+ leak channels  |c K. Staudacher, I. Staudacher, E. Ficker, C. Seyler, J. Gierten, J. Kisselbach, A.-K. Rahm, K. Trappe, P.A. Schweizer, R. Becker, H.A. Katus and D. Thomas 
246 3 0 |a two one three 
246 3 3 |a Carvedilol targets human K 2P 3.1 (TASK1) K + leak channels 
264 1 |c 15 March 2011 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Im Titel ist der Ausdruck "2P" tiefgestellt 
500 |a Im Titel ist das Pluszeichen hochgestellt 
500 |a Gesehen am 20.10.2022 
520 |a BACKGROUND AND PURPOSE Human K2P3.1 (TASK1) channels represent potential targets for pharmacological management of atrial fibrillation. K2P channels control excitability by stabilizing membrane potential and by expediting repolarization. In the heart, inhibition of K2P currents by class III antiarrhythmic drugs results in action potential prolongation and suppression of electrical automaticity. Carvedilol exerts antiarrhythmic activity and suppresses atrial fibrillation following cardiac surgery or cardioversion. The objective of this study was to investigate acute effects of carvedilol on human K2P3.1 (hK2P3.1) channels. EXPERIMENTAL APPROACH Two-electrode voltage clamp and whole-cell patch clamp electrophysiology was used to record hK2P3.1 currents from Xenopus oocytes, Chinese hamster ovary (CHO) cells and human pulmonary artery smooth muscle cells (hPASMC). KEY RESULTS Carvedilol concentration-dependently inhibited hK2P3.1 currents in Xenopus oocytes (IC50= 3.8 µM) and in mammalian CHO cells (IC50= 0.83 µM). In addition, carvedilol sensitivity of native IK2P3.1 was demonstrated in hPASMC. Channels were blocked in open and closed states in frequency-dependent fashion, resulting in resting membrane potential depolarization by 7.7 mV. Carvedilol shifted the current-voltage (I-V) relationship by −6.9 mV towards hyperpolarized potentials. Open rectification, characteristic of K2P currents, was not affected. CONCLUSIONS AND IMPLICATIONS The antiarrhythmic drug carvedilol targets hK2P3.1 background channels. We propose that cardiac hK2P3.1 current blockade may suppress electrical automaticity, prolong atrial refractoriness and contribute to the class III antiarrhythmic action in patients treated with the drug. 
650 4 |a antiarrhythmic drug 
650 4 |a background potassium current 
650 4 |a cardiac arrhythmia 
650 4 |a carvedilol 
650 4 |a cellular excitability 
650 4 |a K2P channel 
650 4 |a leak current 
650 4 |a membrane potential 
700 1 |a Staudacher, Ingo  |d 1983-  |e VerfasserIn  |0 (DE-588)1034185543  |0 (DE-627)74489686X  |0 (DE-576)381801527  |4 aut 
700 1 |a Ficker, Eckhard  |d 1961-  |e VerfasserIn  |0 (DE-588)172595649  |0 (DE-627)69753054X  |0 (DE-576)133455130  |4 aut 
700 1 |a Seyler, Claudia  |d 1976-  |e VerfasserIn  |0 (DE-588)13306476X  |0 (DE-627)533316871  |0 (DE-576)299599523  |4 aut 
700 1 |a Gierten, Jakob  |d 1985-  |e VerfasserIn  |0 (DE-588)1058043544  |0 (DE-627)796339538  |0 (DE-576)41404083X  |4 aut 
700 1 |a Kisselbach, Jana  |e VerfasserIn  |0 (DE-588)1077074859  |0 (DE-627)835963861  |0 (DE-576)445934824  |4 aut 
700 1 |a Rahm, Ann-Kathrin  |d 1988-  |e VerfasserIn  |0 (DE-588)1054163049  |0 (DE-627)791115690  |0 (DE-576)410045217  |4 aut 
700 1 |a Trappe, Kerstin  |d 1981-  |e VerfasserIn  |0 (DE-588)14081616X  |0 (DE-627)622582240  |0 (DE-576)320910229  |4 aut 
700 1 |a Schweizer, Patrick Alexander  |d 1976-  |e VerfasserIn  |0 (DE-588)129886254  |0 (DE-627)48277987X  |0 (DE-576)297887130  |4 aut 
700 1 |a Becker, Rüdiger  |e VerfasserIn  |0 (DE-588)1032502541  |0 (DE-627)738501409  |0 (DE-576)380071061  |4 aut 
700 1 |a Katus, Hugo  |d 1951-  |e VerfasserIn  |0 (DE-588)108916618  |0 (DE-627)577155040  |0 (DE-576)289625076  |4 aut 
700 1 |a Thomas, Dierk  |d 1974-  |e VerfasserIn  |0 (DE-588)123896258  |0 (DE-627)706465601  |0 (DE-576)29393164X  |4 aut 
773 0 8 |i Enthalten in  |t British journal of pharmacology  |d Malden, MA : Wiley, 1946  |g 163(2011), 5, Seite 1099-1110  |h Online-Ressource  |w (DE-627)324659016  |w (DE-600)2029728-2  |w (DE-576)094504113  |x 1476-5381  |7 nnas  |a Carvedilol targets human K2P3.1 (TASK1) K+ leak channels 
773 1 8 |g volume:163  |g year:2011  |g number:5  |g pages:1099-1110  |g extent:12  |a Carvedilol targets human K2P3.1 (TASK1) K+ leak channels 
856 4 0 |u https://doi.org/10.1111/j.1476-5381.2011.01319.x  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1476-5381.2011.01319.x  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20221020 
993 |a Article 
994 |a 2011 
998 |g 123896258  |a Thomas, Dierk  |m 123896258:Thomas, Dierk  |d 910000  |d 910100  |e 910000PT123896258  |e 910100PT123896258  |k 0/910000/  |k 1/910000/910100/  |p 12  |y j 
998 |g 108916618  |a Katus, Hugo  |m 108916618:Katus, Hugo  |d 910000  |d 910100  |e 910000PK108916618  |e 910100PK108916618  |k 0/910000/  |k 1/910000/910100/  |p 11 
998 |g 1032502541  |a Becker, Rüdiger  |m 1032502541:Becker, Rüdiger  |d 50000  |e 50000PB1032502541  |k 0/50000/  |p 10 
998 |g 129886254  |a Schweizer, Patrick Alexander  |m 129886254:Schweizer, Patrick Alexander  |d 910000  |d 910100  |e 910000PS129886254  |e 910100PS129886254  |k 0/910000/  |k 1/910000/910100/  |p 9 
998 |g 14081616X  |a Trappe, Kerstin  |m 14081616X:Trappe, Kerstin  |d 910000  |d 910100  |e 910000PT14081616X  |e 910100PT14081616X  |k 0/910000/  |k 1/910000/910100/  |p 8 
998 |g 1054163049  |a Rahm, Ann-Kathrin  |m 1054163049:Rahm, Ann-Kathrin  |d 50000  |e 50000PR1054163049  |k 0/50000/  |p 7 
998 |g 13306476X  |a Seyler, Claudia  |m 13306476X:Seyler, Claudia  |d 910000  |d 910100  |e 910000PS13306476X  |e 910100PS13306476X  |k 0/910000/  |k 1/910000/910100/  |p 4 
998 |g 1034185543  |a Staudacher, Ingo  |m 1034185543:Staudacher, Ingo  |p 2 
998 |g 1031541551  |a Staudacher, Kathrin  |m 1031541551:Staudacher, Kathrin  |p 1  |x j 
999 |a KXP-PPN1819520641  |e 4199453229 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["K. Staudacher, I. Staudacher, E. Ficker, C. Seyler, J. Gierten, J. Kisselbach, A.-K. Rahm, K. Trappe, P.A. Schweizer, R. Becker, H.A. Katus and D. Thomas"]},"recId":"1819520641","person":[{"role":"aut","family":"Staudacher","display":"Staudacher, Kathrin","given":"Kathrin"},{"family":"Staudacher","role":"aut","given":"Ingo","display":"Staudacher, Ingo"},{"display":"Ficker, Eckhard","given":"Eckhard","role":"aut","family":"Ficker"},{"display":"Seyler, Claudia","given":"Claudia","role":"aut","family":"Seyler"},{"family":"Gierten","role":"aut","given":"Jakob","display":"Gierten, Jakob"},{"given":"Jana","display":"Kisselbach, Jana","role":"aut","family":"Kisselbach"},{"role":"aut","family":"Rahm","given":"Ann-Kathrin","display":"Rahm, Ann-Kathrin"},{"given":"Kerstin","display":"Trappe, Kerstin","family":"Trappe","role":"aut"},{"display":"Schweizer, Patrick Alexander","given":"Patrick Alexander","family":"Schweizer","role":"aut"},{"role":"aut","family":"Becker","given":"Rüdiger","display":"Becker, Rüdiger"},{"given":"Hugo","display":"Katus, Hugo","family":"Katus","role":"aut"},{"role":"aut","family":"Thomas","given":"Dierk","display":"Thomas, Dierk"}],"title":[{"title":"Carvedilol targets human K2P3.1 (TASK1) K+ leak channels","title_sort":"Carvedilol targets human K2P3.1 (TASK1) K+ leak channels"}],"id":{"eki":["1819520641"],"doi":["10.1111/j.1476-5381.2011.01319.x"]},"physDesc":[{"extent":"12 S."}],"relHost":[{"titleAlt":[{"title":"BJP online"}],"disp":"Carvedilol targets human K2P3.1 (TASK1) K+ leak channelsBritish journal of pharmacology","type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 06.02.13"],"pubHistory":["1.1946 -"],"part":{"year":"2011","volume":"163","text":"163(2011), 5, Seite 1099-1110","issue":"5","pages":"1099-1110","extent":"12"},"language":["eng"],"origin":[{"dateIssuedDisp":"1946-","publisher":"Wiley ; Macmillan ; Nature Publ. Group","publisherPlace":"Malden, MA ; Basingstoke ; Basingstoke","dateIssuedKey":"1946"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1476-5381"],"eki":["324659016"],"zdb":["2029728-2"],"doi":["10.1111/(ISSN)1476-5381"]},"title":[{"title_sort":"British journal of pharmacology","title":"British journal of pharmacology","subtitle":"BJP online"}],"recId":"324659016","name":{"displayForm":["The British Pharmacological Society"]}}],"origin":[{"dateIssuedDisp":"15 March 2011","dateIssuedKey":"2011"}],"language":["eng"],"note":["Im Titel ist der Ausdruck \"2P\" tiefgestellt","Im Titel ist das Pluszeichen hochgestellt","Gesehen am 20.10.2022"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"titleAlt":[{"title":"Carvedilol targets human K 2P 3.1 (TASK1) K + leak channels"}]} 
SRT |a STAUDACHERCARVEDILOL1520